|Articles|February 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-12-01-2001
  • Volume 0
  • Issue 0

Generics Debate Escalates

Calls for change reflect that generic products are a therapeutic mainstay and that patients and providers want earlier access to inexpensive medicines.

Articles in this issue

over 24 years ago

States Target DTC Advertising

over 24 years ago

Transparent Moment

over 24 years ago

IFPMA Disputes Doctors Without Boarders Report

over 24 years ago

GSK at Odds with Activists

over 24 years ago

Protecting People Everywhere

over 24 years ago

Opening the Door to Japan

over 24 years ago

Trade Pact Weakens Patent Protections

over 24 years ago

EC Questions Dual Pricing

over 24 years ago

Genetic Test Results Off Limits-For Now

over 24 years ago

Precious Plasma

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content